Acknowledgments & Credits

University of Zurich

The University of Zurich is one of the leading research universities in Europe and offers the widest range of degree programs in Switzerland. The University of Zurich conducts world-class research and has achieved international renown in the fields of medicine, immunology, neuroscience and structural biology. Neurimmune maintains a strong and highly productive partnership with the University of Zurich, especially with the Institute of Regenerative Medicine (IREM).

Bio-Technopark Schlieren-Zurich

In close proximity to the University of Zurich and the Swiss Federal Institute of Technology (ETH), a science park for life science companies and institutions has developed in the last two decades. The science park acquired both national and international significance and hosts today 45 companies and many academic institutions. Neurimmune's offices and laboratories are located at the Bio-Technopark Zurich since 2007 and Neurimmune's COO Michael Salzmann is a Board Member of the Bio-Technopark.

Matthias Meister, lic. iur., LL.M.

Matthias Meister is an attorney-at-law and Partner at HERZER attorneys. He practices company law and contract law and has been supporting Neurimmune since its inception.

Karsten Henco

Serial biotech entrepreneur Dr. Karsten Henco encouraged and advised Roger Nitsch, Christoph Hock and Jan Grimm to found Neurimmune as a University of Zurich spin-off company. Dr. Henco also provided seed capital to Neurimmune in 2007 and served on the Board of Directors.

Ed Stuart

Dr. Ed Stuart is a co-founder and managing partner of HS LifeScience AG. He served for eight months, from September 2007 to May 2008, as advisor and interim CEO of Neurimmune Therapeutics AG.